| Ident. | Authors (with country if any) | Title |
|---|
| 000052 (2021) |
Santanu Santra [Inde] ; Santanab Giri [Inde] ; Madhurima Jana [Inde] | Unraveling the origin of interactions of hydroxychloroquine with the receptor-binding domain of SARS-CoV-2 in aqueous medium. |
| 000064 (2021) |
Michael Marks [Royaume-Uni] ; Pere Millat-Martinez [Espagne] ; Dan Ouchi [Espagne] ; Chrissy H. Roberts [Royaume-Uni] ; Andrea Alemany [Espagne] ; Marc Corbacho-Monné [Espagne] ; Maria Ubals [Espagne] ; Aurelio Tobias [Espagne] ; Cristian Tebé [Espagne] ; Ester Ballana [Espagne] ; Quique Bassat [Espagne] ; Bàrbara Baro [Espagne] ; Martí Vall-Mayans [Espagne] ; Camila G-Beiras [Espagne] ; Nuria Prat [Espagne] ; Jordi Ara [Espagne] ; Bonaventura Clotet [Espagne] ; Oriol Mitjà [Papouasie-Nouvelle-Guinée] | Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. |
| 000088 (2021) |
Minas Theodore Coroneo [Australie] | The eye as the discrete but defensible portal of coronavirus infection. |
| 000181 (2021) |
Pravindra Kumar [Inde] ; Ashok Kumar Sah [Inde] ; Greesham Tripathi [Inde] ; Anjali Kashyap [Inde] ; Avantika Tripathi [Inde] ; Rashmi Rao [Inde] ; Prabhu C. Mishra [Inde] ; Koustav Mallick [Inde] ; Amjad Husain [Inde] ; Manoj Kumar Kashyap [Inde] | Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19. |
| 000388 (2021) |
Iqbal Hussain [Arabie saoudite] ; Afzal Hussain [Arabie saoudite] ; Mohamed F. Alajmi [Arabie saoudite] ; Md Tabish Rehman [Arabie saoudite] ; Samira Amir [Arabie saoudite] | Impact of repurposed drugs on the symptomatic COVID-19 patients. |
| 000441 (2021) |
Asokan Devarajan [États-Unis] ; Marmar Vaseghi [États-Unis] | Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights. |
| 000668 (2021) |
Saad I. Mallah [Oman] ; Omar K. Ghorab ; Sabrina Al-Salmi ; Omar S. Abdellatif [Canada] ; Tharmegan Tharmaratnam [Irlande (pays)] ; Mina Amin Iskandar ; Jessica Atef Nassef Sefen ; Pardeep Sidhu ; Bassam Atallah [Émirats arabes unis, États-Unis] ; Rania El-Lababidi [Émirats arabes unis] ; Manaf Al-Qahtani [Oman] | COVID-19: breaking down a global health crisis. |
| 000745 (2021) |
Yamei Zhang [Irlande (pays)] ; Siobhan Gargan [Irlande (pays)] ; Yongxu Lu [Royaume-Uni] ; Nigel J. Stevenson [Irlande (pays), Bahreïn] | An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity. |
| 000761 (2021) |
S Udhaya Kumar [Inde] ; N Madhana Priya [Inde] ; S R Nithya [Inde] ; Priyanka Kannan [Inde] ; Nikita Jain [Inde] ; D Thirumal Kumar [Inde] ; R. Magesh [Inde] ; Salma Younes [Qatar] ; Hatem Zayed [Qatar] ; C George Priya Doss [Inde] | A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing. |
| 000786 (2021) |
Muhammad Harris Shoaib [Pakistan] ; Farrukh Rafiq Ahmed [Pakistan] ; Muhammad Sikandar [Pakistan] ; Rabia Ismail Yousuf [Pakistan] ; Muhammad Talha Saleem [Pakistan] | A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management. |
| 000788 (2021) |
Chris R. Triggle [Qatar] ; Devendra Bansal [Qatar] ; Hong Ding [Qatar] ; Md Mazharul Islam [Qatar] ; Elmoubashar Abu Baker Abd Farag [Qatar] ; Hamad Abdel Hadi [Qatar] ; Ali A. Sultan [Qatar] | A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. |
| 000897 (2020) |
Molly C. Easterlin [États-Unis] ; Theodore De Beritto [États-Unis] ; Amy M. Yeh [États-Unis] ; Fiona B. Wertheimer [États-Unis] ; Rangasamy Ramanathan [États-Unis] | Extremely Preterm Infant Born to a Mother With Severe COVID-19 Pneumonia. |
| 000913 (2020) |
Md Tanvir Kabir [Bangladesh] ; Md Sahab Uddin [Bangladesh] ; Md Farhad Hossain [Bangladesh, Corée du Sud] ; Jawaher A. Abdulhakim [Arabie saoudite] ; Md Asraful Alam [République populaire de Chine] ; Ghulam Md Ashraf [Arabie saoudite] ; Simona G. Bungau [Roumanie] ; May N. Bin-Jumah [Arabie saoudite] ; Mohamed M. Abdel-Daim [Arabie saoudite, Égypte] ; Lotfi Aleya [France] | nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics. |
| 000923 (2020) |
Alexandre Dumusc [Suisse] ; Diana Dan [Suisse] | [Rheumatology and COVID-19]. |
| 000978 (2020) |
Lubna Kamani [Pakistan] | What gastroenterologists should know during COVID-19 Pandemic! |
| 000997 (2020) |
Zeinab Imani-Saber [Iran] ; Hajar Vaseghi [Iran] ; Mojdeh Mahdian [Iran] ; Fatemeh Safari [Iran] ; Mohsen Ghadami [Iran] | Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk. |
| 000A19 (2020) |
Vasilios Tzilas [Grèce] ; Demosthenes Bouros [Grèce] | Update on COVID-19: A teleconference with the Paediatric Virology Study Group (Review). |
| 000A91 (2020) |
Rishita Pujari [États-Unis] ; Mary V. Thommana [États-Unis] ; Brisandi Ruiz Mercedes [États-Unis] ; Ayna Serwat [États-Unis] | Therapeutic Options for COVID-19: A Review. |
| 000B18 (2020) |
Pan Zhai [République populaire de Chine] ; Yanbing Ding [République populaire de Chine] ; Xia Wu [République populaire de Chine] ; Junke Long [République populaire de Chine] ; Yanjun Zhong [République populaire de Chine] ; Yiming Li [République populaire de Chine] | The epidemiology, diagnosis and treatment of COVID-19. |
| 000B23 (2020) |
Kuma Diriba [Éthiopie] ; Ephrem Awulachew [Éthiopie] ; Eyob Getu [Éthiopie] | The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. |
| 000B34 (2020) |
Kirill Gorshkov ; Catherine Z. Chen ; Robert Bostwick ; Lynn Rasmussen ; Miao Xu ; Manisha Pradhan ; Bruce Nguyen Tran ; Wei Zhu ; Khalida Shamim ; Wenwei Huang ; Xin Hu ; Min Shen ; Carleen Klumpp-Thomas ; Zina Itkin ; Paul Shinn ; Anton Simeonov ; Sam Michael ; Matthew D. Hall ; Donald C. Lo ; Wei Zheng | The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators. |
